Belviq's Sales Will Disappoint: Demographics Matter
Arena Pharmaceuticals has now received its long anticipated scheduling for Belviq from the DEA , and its fate in Europe , at least in the short-term, is a known for investors.
Join the discussion below, or Read more at Seeking Alpha.
#1 Jun 8, 2013
This is terrible news as I am a CNPR (Certified National Pharmaceutical representative, and I am always looking for new drugs to sell. If you want information on pharmaceutical sales look up my blog http://www.brianbrowncnpr.com
Add your comments below
|Merck's shingles vaccine, Zostavax, recommended... (Jun '08)||15 hr||StevenB||76|
|Obama asks Congress for $1.8 billion to fight Zika||Fri||Science and Math||13|
|Premature Ejaculation Drug (Jul '06)||Jan 31||Dr Wu||33|
|Drugmaker Pfizer sees profit gain after acquisi... (May '10)||Jan 31||Noell||18|
|Vivus Wins FDA Approval (Aug '12)||Jan 31||Tara||13|
|Earnings Preview: Pfizer to report 2Q earnings (Aug '10)||Jan 31||Sharolyn||18|
|Q1 2016 EPS Estimates for McKesson Co. (MCK) De...||Jan 30||Syntax Error||1|
Find what you want!
Search Biotech Forum Now
Copyright © 2016 Topix LLC